To compare TDF and ETV on the risk of HCC and mortality or liver transplantation (LT) in a propensity-matched, large-scale cohort with follow-up period of 5 years
Latest Information Update: 11 Nov 2019
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
Most Recent Events
- 11 Nov 2019 New trial record
- 31 Oct 2019 Results published in the Gut